Inventor · disambiguated record
Khurram Jamil
Also filed as: JAMIL KHURRAM
2 granted patents·19 pending applications·16 citations·filing 2011–2025
58Inventor score
Files withMALLINCKRODT PHARMACEUTICALS IRELAND LTD13MALLINCKRODT HOSPITAL PRODUCTS IP LTD5USANSKY HELEN H2Mallinckrodt Hospital Products IP Unlimited Company1
Top patents by PatentIndex Score
21 records- 0185US10335452B2Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2015·Granted Jul 2, 2019·13 cites·28 claims
- 0281US2024374674A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0381US2024374676A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0481US2024374675A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0581US2024366710A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0679US2024238364A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 0774US2023054888A1Methods and compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 0870US2023108970A1Methods and compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 0970US2023126586A1Methods and compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 1069US2024307483A1Compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2024·Application pending·0 cites
- 1168US2022143132A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 1267US2021290725A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2021·Application pending·0 cites
- 1366US8778413B2Dosing regimens and methods of treatment using carbon monoxideUSANSKY HELEN H·Filed 2011·Granted Jul 15, 2014·3 cites·5 claims
- 1465US2024156895A1Compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2022·Application pending·0 cites
- 1565US2025276033A1Compositions for improving kidney function in patients with hepatorenal syndromeMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2025·Application pending·0 cites
- 1664US2020046798A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2019·Application pending·0 cites
- 1761US2020246418A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2020·Application pending·0 cites
- 1846US2019328831A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2019·Application pending·0 cites
- 1944US2020237856A1Method of treating patients with hepatorenal syndrome type 1MALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2020·Application pending·0 cites
- 2041US2014287066A1Dosing regimens and methods of treatment using carbon monoxideUSANSKY HELEN H·Filed 2014·Application pending·0 cites
- 2139US2021128676A1Method of treating patients with hepatorenal syndrome type 1 and low mean arterial pressureMallinckrodt Hospital Products IP Unlimited Company·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Khurram Jamil files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →